Segall Bryant & Hamill’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Segall Bryant & Hamill's HALO Position: Q2 2026 in Review
Segall Bryant & Hamill increased its Halozyme (HALO) stake by 6.7% in Q2 2026, buying an estimated $1.35M and bringing the position to 317,924 shares worth $24.9M. The position accounts for 0.3% of the portfolio, ranked #103.
Segall Bryant & Hamill first reported a position in HALO in Q1 2014 and has held it in 22 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Segall Bryant & Hamill held 317,924 shares of Halozyme worth $24.9M as of Q2 2026.
- Segall Bryant & Hamill bought 19,868 Halozyme shares in Q2 2026, an estimated $1.35M.
- Halozyme made up 0.3% of Segall Bryant & Hamill's portfolio in Q2 2026, its #103 holding.
- Segall Bryant & Hamill first reported a position in Halozyme in Q1 2014 and has held it in 22 quarters since.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.